AZTA — Azenta, Inc.
$36.50+1.36%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for AZTA in the TickerWise workspace.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Company profile
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
- Exchange: NASDAQ
- Employees: 3,000
- Website: https://www.azenta.com
Latest SEC filings for AZTA
Latest AZTA news
- Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights Read article
- ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Read article
- Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Read article
- ROSEN, A LEADING NATIONAL FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Read article
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Read article
- Azenta shutting three Multiomics lab sites under restructuring plan Read article
- Azenta Inc (AZTA) Shares Fall 7.9% -- What GF Score of 83 Tells Investors Read article
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.